{"public_id":"cl_1d7eac642272fa8377a0418a5d16b07b","status":"active","superseded_by_public_id":null,"corpus_id":36405254,"text":"All ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates were resistant to cefotaxime when CLSI 2010-12 criteria were applied.","confidence":0.9,"paper":{"corpus_id":36405254,"title":"Antimicrobial resistance to cefotaxime and ertapenem in Enterobacteriaceae: the effects of altering clinical breakpoints.","url":"https://sah.borca.ai/papers/36405254"},"contributors":[{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["extraction"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.9,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_0851992a9cc193e59656a52cff321923","name":"cefotaxime","description":"A beta-lactam antibiotic tested for susceptibility in Enterobacteriaceae isolates.","types":["antibiotic"],"url":"https://sah.borca.ai/concepts/co_0851992a9cc193e59656a52cff321923"},{"public_id":"co_93e43dba19196e4d6188f45a37c5c620","name":"CLSI 2010-12 guidelines","description":"The updated CLSI breakpoints for Enterobacteriaceae covering the 2010-2012 period, used for cefotaxime susceptibility.","types":["guideline version"],"url":"https://sah.borca.ai/concepts/co_93e43dba19196e4d6188f45a37c5c620"},{"public_id":"co_b2555a26000ae8d2ee252314a3f148be","name":"ESBL-producing Klebsiella pneumoniae","description":"Klebsiella pneumoniae isolates that produce extended-spectrum beta-lactamase, conferring resistance to beta-lactam antibiotics.","types":["organism"],"url":"https://sah.borca.ai/concepts/co_b2555a26000ae8d2ee252314a3f148be"},{"public_id":"co_f0ed35edb030c4d35f4b03240f68f597","name":"ESBL-producing Escherichia coli","description":"Escherichia coli isolates that produce extended-spectrum beta-lactamase, conferring resistance to beta-lactam antibiotics.","types":["organism"],"url":"https://sah.borca.ai/concepts/co_f0ed35edb030c4d35f4b03240f68f597"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_1d7eac642272fa8377a0418a5d16b07b"}